Loading...

Factor XIa inhibitors: A review of patent literature

INTRODUCTION: Anticoagulants are the mainstay for prevention and/or treatment of thrombotic disorders. Each clinically used anticoagulant is associated with significant adverse consequences, especially bleeding. Factor XIa (FXIa), a key factor involved in the amplification of procoagulation signal,...

Full description

Saved in:
Bibliographic Details
Published in:Expert Opin Ther Pat
Main Authors: Al-Horani, Rami A., Desai, Umesh R.
Format: Artigo
Language:Inglês
Published: 2016
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4941829/
https://ncbi.nlm.nih.gov/pubmed/26881476
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/13543776.2016.1154045
Tags: Add Tag
No Tags, Be the first to tag this record!